A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

Daily subcutaneous injections of pegilodecakin up to 12 months

Day 1 of every 21 day cycle

Intravenous administration on Day 1 and 2 of every 14 day cycle

Intravenous administration of the gemcitabine/nab-paclitaxel regimen on Day 1, 8 and 15 of each 28 day treatment cycle.

Capecitabine will be administered orally twice daily for 14 days out of every 21 days.

Pazopanib will be administered orally daily continuously

Pembrolizumab will be administered intravenously on Day 1 of every 21 day cycle.

"Paclitaxel will be administered intravenously on Days 1, 8, 15 of each cycle (28 days= 1 cycle)~• Paclitaxel 80 mg/ m2 IV"

Nivolumab on Day 1 of each cycle (14 days = 1 cycle)

gemcitabine and carboplatin on Days 1, 8 of each cycle (21 days = 1 cycle)